← TrialMatch
HomeTrials

Personalized Obstructive Sleep Apnea Treatment and Effects on Alzheimer's Disease Biomarke

The purpose of this research is to see how effective the Personalized obstructive sleep apnea (OSA) Treatment Adherence Model called PRAISE is in helping the patient stick to the physician recommended OSA treatment plan Positive Airway Pressure (PAP).

Condition(s)Sleep Apnea
StatusRecruiting
PhaseNA
Study typeInterventional
SummaryThe purpose of this research is to see how effective the Personalized obstructive sleep apnea (OSA) Treatment Adherence Model called PRAISE is in helping the patient stick to the physician recommended OSA treatment plan Positive Airway Pressure (PAP).
Who can participateInclusion Criteria: * Self-reported race/ethnicity as African American, African, Caribbean or black * Ages 60-85 years * accessible by phone * OSA diagnosis * consent, including permission to release medical data Exclusion Criteria: * progressive illnesses in which disability or death is expected within 1 year * impaired cognitive/ functional ability precluding participation * intention to move within the year * and a family member currently enrolled.
Ages60 Years to 85 Years
SexAll
Lead sponsorUniversity of Miami
LocationsMiami, Florida, United States
Start date2024-03-19
NCT IDNCT06089161
Official listinghttps://clinicaltrials.gov/study/NCT06089161

🔍 Search all trials →